XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 22,453 $ 42,592 $ 63,696
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and accretion expense 75,983 77,158 80,625
Amortization of deferred financing costs 1,937 3,287 2,788
Credit loss expense 157 40 232
Deferred income tax (benefit) expense (6,147) 1,572 (1,753)
Equity-based employee and director compensation expense 1,508 3,031 2,294
Gain on dispositions and lease terminations, net (4,966) (4,737) (1,143)
Changes in operating assets and liabilities, net of acquisitions (3,143) (5,860) 14,578
Net cash provided by operating activities 87,782 117,083 161,317
Cash flows from investing activities:      
Principal payments received on notes receivable 152 213 203
Proceeds from sale of assets 35,374 6,234 13,344
Capital expenditures (26,318) (34,628) (30,351)
Lease terminations payments to Applegreen, including inventory purchases (25,517)    
Cash paid in connection with acquisitions, net of cash acquired     (29,594)
Net cash used in investing activities (16,309) (28,181) (46,398)
Cash flows from financing activities:      
Borrowings under revolving credit facilities 113,000 240,900 114,100
Repayments on revolving credit facilities (101,500) (91,037) (138,538)
Borrowings under the Term Loan Facility     1,120
Repayments on the Term Loan Facility   (158,980) (24,600)
Net proceeds from issuance of preferred membership interests     24,430
Payments of finance lease obligations (3,082) (2,890) (2,724)
Payments of deferred financing costs (74) (7,106) (474)
Distributions paid on distribution equivalent rights (260) (241) (202)
Income tax distributions paid on preferred membership interests (1,312) (900)  
Distributions paid on common units (79,854) (79,712) (79,625)
Net cash used in financing activities (73,082) (99,966) (106,513)
Net (decrease) increase in cash and cash equivalents (1,609) (11,064) 8,406
Cash and cash equivalents at beginning of period 4,990 16,054 7,648
Cash and cash equivalents at end of period $ 3,381 $ 4,990 $ 16,054